Press Releases

Press Releases

    Date Title View
    08/03/22
    Summary ToggleHorizon Therapeutics plc Reports Second-Quarter 2022 Financial Results and Revises Full-Year 2022 Net Sales and Adjusted EBITDA Guidance
    07/25/22
    Summary ToggleHorizon Therapeutics plc Named a Best Company for Multicultural Women
    PDF Version
    07/21/22
    Summary ToggleHorizon Therapeutics plc Announces Inaugural #RAREis Global Advocate Grant Recipients
    PDF Version
    07/11/22
    Summary ToggleHorizon Therapeutics plc Announces Wanda Durant Has Joined Olympian Gail Devers to Raise Awareness of Thyroid Eye Disease Among Graves’ Disease Community
    PDF Version
    07/08/22
    Summary ToggleFDA Approves KRYSTEXXA® (pegloticase) Injection Co-Administered With Methotrexate, Expanding the Labeling to Help More People with Uncontrolled Gout Achieve a Complete Response to Therapy
    PDF Version
    07/07/22
    Summary ToggleHorizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webcast on Aug. 3, 2022
    PDF Version
    06/24/22
    Summary ToggleNew Analysis Finds UPLIZNA® (inebilizumab) Effective Among European Populations with Neuromyelitis Optica Spectrum Disorder (NMOSD)
    PDF Version
    06/15/22
    Summary ToggleHorizon Therapeutics plc Submits Regulatory Filing for UPLIZNA® (inebilizumab) in Brazil
    PDF Version
    06/15/22
    Summary ToggleHorizon Therapeutics plc Named One of the Fortune Best Workplaces in Chicago™
    PDF Version
    06/11/22
    Summary ToggleAnalysis of Pooled Data from TEPEZZA® (teprotumumab-trbw) Clinical Trials Reinforces Safety Profile in People with Thyroid Eye Disease (TED)
    PDF Version
    Displaying 31 - 40 of 701 results